ℹ️ Compiled from public regulatory records · Last regulator revision: July 11, 2022🚩 Report this page
Tixagevimab
Active ingredient
Sold as EVUSHELD
GB MHRA
- Drug class
- -
- Availability
- See label
- Markets covered
- 1
- Products on record
- 1
Overview
Tixagevimab is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 1 | July 11, 2022 |
GBUnited Kingdom· MHRA
1 product
Sources & citations
- [1]MHRA (UK) · PLGB179010360 · revised July 11, 2022
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.